antipsychotic | CARLAT PUBLISHING

Top 10 Findings: Alcohol, ADHD, and Antipsychotics

October 28, 2024

Chris Aiken, MD and Kellie Newsome, PMHNP

A new med combo for alcohol use disorder, antipsychotic dose reduction in schizophrenia, and two new tips for using stimulants in ADHD.

Cobenfy: A New Antipsychotic

October 7, 2024

Chris Aiken, MD and Kellie Newsome, PMHNP

KarXT (Cobenfy) is the first antipsychotic that doesn’t block dopamine. We trace the origins of this new drug to a South Asian herb used for over 5,000 years, up to the three EMERGENT trials that led to its FDA approval.

Research Update

Does Menopause Increase Risk of Psychosis?

July 1, 2024

Briana Tillman, MD

Briana Tillman, MD. Dr. Tillman has no financial relationships with companies related to this material.

This comprehensive study highlights the need for gender-specific treatment in schizophrenia spectrum disorders, revealing that hormonal changes call for lower antipsychotic doses for female patients under 45 and higher doses for those who are post-menopausal.

Clinical Update

Tapering Antipsychotics

November 1, 2023

Charmi Patel Rao, MD, DFAACAP

Charmi Patel Rao, MD, DFAACAP. Director of Psychiatric Services, Positive Development; Health Sciences Assistant Clinical Professor, Department of Psychiatry, Child and Adolescent Psychiatry; UCSD, San Diego, CA.

Dr. Patel Rao has no financial relationships with companies related to this material.

Antipsychotics offer remarkable, even lifesaving treatment for children and adolescents, however, their side effects include metabolic and neurologic problems, including neurotoxicity. This clinical update guides you through a rational process for employing these powerful medications when necessary but also reducing and discontinuing them when possible.

Expert Q&A

Treating Bipolar Disorder During Pregnancy

October 3, 2023

Lauren Osborne, MD

Lauren Osborne, MD.

Vice Chair of Clinical Research, Department of Obstetrics & Gynecology, Weill Cornell Medicine, New York, NY.

Dr. Osborne has no financial relationships with companies related to this material.

The management of bipolar disorder during pregnancy can be tricky. Some medications can be harmful to the fetus, and others need to be adjusted carefully due to changes in kidney and liver function. We walk you through the important considerations to keep in mind when working with these patients.

Confused About Acute Confusional States? A Primer on Delirium

June 5, 2023

Victoria Hendrick, MD and Prabhjot Gill

Delirium is widespread among patients in ICUs and surgery units. In this podcast, we will review the workup and management of this common condition and give you tips to help prevent it in high-risk patients

Psychopharm Commandment 7A: Red Flags & Controlled Meds

April 3, 2023

Chris Aiken, MD and Kellie Newsome, PMHNP

The DEA has warned pharmacists to watch for Red Flags in controlled prescriptions, and we’ll show you what they are and how to use them therapeutically in practice.

Clinical Update

Confused About Acute Confusional States? A Primer on Delirium

April 1, 2023

Michael Strong, MD and Alexander Thompson, MD, MBA, MPH

Michael Strong, MD. Assistant professor of clinical psychiatry, Perelman School of Medicine at the University of Pennsylvania. Philadelphia, PA.
Alexander Thompson, MD, MBA, MPH. Clinical professor of psychiatry and emergency medicine; director, C-L Psychiatry, University of Iowa. Iowa City, IA.
Dr. Strong and Dr. Thompson have no financial relationships with companies related to this material.

Delirium is widespread among patients in ICUs and surgery units. We review the workup and management of this common condition and give you tips to help prevent it in high-risk patients.

SAINT TMS Cleared for Treatment-Resistant Depression

September 12, 2022

Chris Aiken, MD and Kellie Newsome, PMHNP

On 9/6/22 the FDA approved Stanford’s SAINT Neuromodulation, an accelerated version of TMS that has raised hopes with unusually high remission rates.

Clinical Update

Treatment of Antipsychotic-Induced Weight Gain

September 1, 2022

Brian Miller, MD, PhD, MPH

Brian Miller, MD, PhD, MPH. Professor of Psychiatry at the Medical College of Georgia, Augusta, and President of the Georgia Psychiatric Physicians Association.

Dr. Miller, author of this educational activity, receives research support from Augusta University; the National Institute of Mental Health; the Brain and Behavior Research Foundation; and the Stanley Medical Research Institute. Relevant financial relationships listed for the author have been mitigated.

From lifestyle changes to liraglutide, Brian Miller details best practices for managing this insidious side effect.